5 July 2021 - Deborah Wilkes
Premium
GlaxoSmithKline (GSK ) will “evaluate any alternative options for Consumer Healthcare that may arise”, according to the company’s board, which says it is close to appointing a chief executive officer designate for the business ahead of the proposed separation.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.